What is the recommended treatment for Helicobacter pylori (H. pylori) infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Treatment for Helicobacter pylori Infection

In areas of high clarithromycin resistance (≥15%), bismuth quadruple therapy for 14 days is the recommended first-line treatment for H. pylori infection, while in areas of low clarithromycin resistance (<15%), PPI-clarithromycin-containing triple therapy for 14 days is recommended. 1

First-Line Treatment Options

Based on Clarithromycin Resistance:

  1. High Clarithromycin Resistance Areas (≥15%):

    • Bismuth quadruple therapy for 14 days (85% eradication rate) 1
    • Components: PPI + bismuth + tetracycline + metronidazole
    • Alternative: Concomitant non-bismuth quadruple therapy for 14 days (80% eradication rate) 1
  2. Low Clarithromycin Resistance Areas (<15%):

    • Standard triple therapy for 14 days (85% eradication rate) 1
    • Components: PPI + clarithromycin + amoxicillin
    • Alternative: Bismuth quadruple therapy for 14 days 1

Special Treatment Considerations

For Patients with Penicillin Allergy:

  • Avoid amoxicillin-containing regimens 1
  • Consider allergy testing as many reported penicillin allergies are not true allergies 1
  • Alternative regimen: bismuth quadruple therapy without amoxicillin

For Treatment-Experienced Patients:

  • Use antibiotics not previously used or for which resistance is unlikely 2
  • Second-line options: 14-day levofloxacin triple therapy or 14-day bismuth quadruple therapy (if not previously used) 2
  • For multiple treatment failures, antimicrobial susceptibility testing is recommended 2

For Patients with Duodenal Ulcer:

  • Triple therapy with amoxicillin, clarithromycin, and lansoprazole 3
  • For patients allergic or intolerant to clarithromycin, or with suspected resistance: dual therapy with amoxicillin and lansoprazole 3

Optimizing Treatment Success

  1. Acid Suppression:

    • Use high-dose potent proton pump inhibitors or vonoprazan for adequate acid suppression 2
    • Take medications at the start of a meal to minimize gastrointestinal intolerance 3
  2. Treatment Duration:

    • All regimens should be administered for 14 days to maximize eradication rates 1, 2
    • Shorter courses have lower eradication rates 1
  3. Patient Counseling:

    • Inform patients about potential darkening of stool from bismuth 1
    • Advise avoiding alcohol while taking metronidazole due to disulfiram-like reaction 1
    • Emphasize importance of completing the full course, as poor compliance significantly reduces eradication rates 1

Post-Treatment Follow-up

  • Test for eradication at least 4 weeks after completing treatment 1
  • Use urea breath test or monoclonal stool antigen test 1
  • Discontinue PPIs at least 2 weeks before testing to avoid false negatives 1
  • The stool antigen test 7 days after treatment completion can be predictive of eradication success 4

Common Pitfalls to Avoid

  1. Inadequate treatment duration - ensure full 14-day course 1
  2. Failure to test for eradication after treatment 1
  3. Poor patient compliance - provide clear instructions and emphasize importance 1
  4. Not stopping PPIs before testing - can lead to false negative results 1
  5. Misdiagnosis of GERD as H. pylori infection - carefully assess predominant symptoms 1

Special Populations

  • Pregnancy: Avoid invasive diagnostic procedures unless absolutely necessary; if needed, perform preferably in second trimester 1
  • Breastfeeding: Most medications used for H. pylori treatment are compatible with breastfeeding 1
  • Patients with risk factors for gastric cancer: Consider surveillance endoscopy every 3 years 1

References

Guideline

Diagnosis and Treatment of Helicobacter pylori Infection

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Management of Helicobacter pylori infection.

JGH open : an open access journal of gastroenterology and hepatology, 2023

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.